Medicare Part D Coverage Gap Discount Proposal Challenged In Study
Executive Summary
Analysis sponsored by a biopharma-backed group challenges MedPAC proposal for changing Part D procedures in a way that could reduce beneficiary incentives to choose high-cost branded drugs while in the coverage gap.